Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response

Am J Transplant. 2022 May 9. doi: 10.1111/ajt.17091. Online ahead of print.

Karsten Midtvedt¹, John Torgils Vaage^{2

3}, Kristian Heldal¹, Ludvig A Munthe^{2

3

4}, Fridtjof Lund-Johansen³, Anders Åsberg^{1

5

6}

¹ Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
² Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
³ Department of Immunology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁴ KG Jebsen Centre for B Cell Malignancies, University of Oslo, Oslo, Norway.
⁵ Norwegian Renal Registry, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
⁶ Department of Pharmacy, University of Oslo, Oslo, Norway.

No abstract available

Publication types